Los Angeles Times Examines 'Salvage Therapy' Among HIV-Positive People Who Have Developed Drug Resistance
Main Category: HIV / AIDSAlso Included In: Infectious Diseases / Bacteria / Viruses; MRSA / Drug Resistance
Article Date: 04 Jan 2007 - 16:00 PDT
| Patient / Public: | ![]() |
4.5 (2 votes) |
| Healthcare Prof: | ![]() |
The Los Angles Times on Monday examined the use of "salvage therapy" among HIV-positive people who have developed a "bedeviling resistance" to antiretroviral drugs. An estimated 40,000 HIV-positive people in the U.S. have developed resistance to available antiretrovirals and rely on a "complicated and ever changing" combination of available drugs to "keep them alive long enough for entirely new drugs to arrive," according to the Times. The clinical findings for one such drug, called integrase inhibitors, were highlighted at last year's XVI International AIDS Conference in Toronto, the Times reports. According to the newly published clinical trial results, integrase inhibitors when used in combination therapy reduced almost 100% of the participants' viral loads to undetectable levels. The combination therapy had the same effect in 72% of study participants on salvage therapy, according to the Times. "They tested it on some people who were in deep, deep salvage therapy, and even those people did remarkably well," Steven Deeks of the University of California-San Francisco said, adding, "It seems to be a truly phenomenal drug that everyone is sort of a little bit in awe of right now and is changing the whole way we think about the management of these patients" (Ricci, Los Angeles Times, 1/2).
"Reprinted with permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation . © 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.
Visit our hiv / aids section for the latest news on this subject.
MLA
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/60034.php>
APA
http://www.medicalnewstoday.com/releases/60034.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




